BOK Financial’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.05M Sell
7,678
-3,231
-30% -$875K 0.03% 324
2025
Q4
$2.74M Sell
10,909
-496
-4% -$132K 0.04% 281
2025
Q3
$3.27M Sell
11,405
-437
-4% -$117K 0.05% 262
2025
Q2
$3.11M Sell
11,842
-407
-3% -$99.1K 0.05% 273
2025
Q1
$2.85M Sell
12,249
-219
-2% -$53.1K 0.05% 275
2024
Q4
$2.89M Sell
12,468
-5,999
-32% -$1.38M 0.05% 276
2024
Q3
$3.97M Sell
18,467
-2,974
-14% -$654K 0.07% 229
2024
Q2
$4.36M Sell
21,441
-1,077
-5% -$219K 0.08% 217
2024
Q1
$4.87M Sell
22,518
-148
-0.7% -$32.6K 0.09% 214
2023
Q4
$5.15M Sell
22,666
-37
-0.2% -$7.77K 0.1% 191
2023
Q3
$4.53M Sell
22,703
-3,766
-14% -$794K 0.1% 196
2023
Q2
$5.49M Buy
26,469
+179
+0.7% +$34.7K 0.11% 177
2023
Q1
$5.18M Sell
26,290
-24,041
-48% -$4.95M 0.11% 186
2022
Q4
$10.2M Sell
50,331
-3,428
-6% -$670K 0.19% 120
2022
Q3
$9.46M Sell
53,759
-1,557
-3% -$319K 0.19% 122
2022
Q2
$11.1M Buy
55,316
+628
+1% +$134K 0.21% 108
2022
Q1
$12.4M Buy
54,688
+4,756
+10% +$1.12M 0.2% 114
2021
Q4
$13.5M Buy
49,932
+17,357
+53% +$4.3M 0.21% 106
2021
Q3
$7.88M Buy
+32,575
New +$8.21M 0.14% 162
2021
Q1
$821K Buy
3,747
+739
+25% +$148K 0.01% 597
2020
Q4
$526K Sell
3,008
-160
-5% -$27.6K 0.01% 657
2020
Q3
$512K Sell
3,168
-217
-6% -$34.4K 0.01% 616
2020
Q2
$483K Sell
3,385
-290
-8% -$40.1K 0.01% 636
2020
Q1
$399K Buy
3,675
+1,624
+79% +$234K 0.01% 632
2019
Q4
$299K Sell
2,051
-57
-3% -$8.23K 0.01% 797
2019
Q3
$304K Sell
2,108
-3,793
-64% -$554K 0.01% 779
2019
Q2
$876K Buy
5,901
+3,968
+205% +$554K 0.02% 520
2019
Q1
$255K Buy
+1,933
New +$238K 0.01% 811
2018
Q4
Sell
-2,134
Closed -$319K 916
2018
Q3
$319K Buy
2,134
+28
+1% +$4.26K 0.01% 776
2018
Q2
$324K Sell
2,106
-2,354
-53% -$355K 0.01% 786
2018
Q1
$620K Sell
4,460
-39
-0.9% -$5.73K 0.02% 583
2017
Q4
$616K Buy
4,499
+25
+0.6% +$3.3K 0.02% 613
2017
Q3
$581K Sell
4,474
-2,280
-34% -$304K 0.02% 623
2017
Q2
$895K Sell
6,754
-34
-0.5% -$4.16K 0.03% 496
2017
Q1
$836K Sell
6,788
-293
-4% -$34.7K 0.03% 526
2016
Q4
$781K Sell
7,081
-22,408
-76% -$2.49M 0.03% 528
2016
Q3
$3.48M Buy
29,489
+1,655
+6% +$195K 0.12% 200
2016
Q2
$3.11M Buy
27,834
+8,524
+44% +$917K 0.11% 207
2016
Q1
$1.94M Buy
19,310
+13,619
+239% +$1.31M 0.07% 303
2015
Q4
$604K Sell
5,691
-809
-12% -$83.5K 0.02% 536
2015
Q3
$606K Sell
6,500
-734
-10% -$75.9K 0.02% 524
2015
Q2
$753K Buy
7,234
+1,824
+34% +$190K 0.03% 511
2015
Q1
$586K Buy
+5,410
New +$556K 0.02% 526
2014
Q4
Sell
-24,269
Closed -$2.12M 747
2014
Q3
$2.12M Sell
24,269
-752
-3% -$67.9K 0.07% 290
2014
Q2
$2.2M Buy
25,021
+17,044
+214% +$1.48M 0.07% 297
2014
Q1
$673K Buy
7,977
+573
+8% +$45.7K 0.02% 540
2013
Q4
$582K Sell
7,404
-3,392
-31% -$289K 0.02% 580
2013
Q3
$919K Sell
10,796
-83
-0.8% -$6.99K 0.03% 432
2013
Q2
$936K Buy
+10,879
New +$903K 0.04% 401

Other funds holding LH

BOK Financial's LH Position: Q1 2026 in Review

BOK Financial reduced its Labcorp (LH) stake by 30% in Q1 2026, selling an estimated $875K and leaving 7,678 shares worth $2.05M. The position accounts for 0.03% of the portfolio, ranked #324.

BOK Financial first reported a position in LH in Q2 2013 and has held it in 49 quarters since. The position peaked at $13.5M in Q4 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • BOK Financial held 7,678 shares of Labcorp worth $2.05M as of Q1 2026.
  • BOK Financial sold 3,231 Labcorp shares in Q1 2026, an estimated $875K.
  • Labcorp made up 0.03% of BOK Financial's portfolio in Q1 2026, its #324 holding.
  • BOK Financial first reported a position in Labcorp in Q2 2013 and has held it in 49 quarters since.
  • BOK Financial's Labcorp position peaked at $13.5M in Q4 2021.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on BOK Financial's 13F filing for Q1 2026, filed 8 May 2026.